XDS logo

News & Insights

How to Choose a Pharma SEO Agency: 8 Evaluation Criteria for Regulated Life Sciences in 2026

XDS is a digital agency

Last Updated: July 30, 2026

Choosing an SEO agency for a pharmaceutical brand differs from choosing one for a SaaS company. The wrong partner will not just underperform, it can create real regulatory exposure. This guide covers the eight criteria that matter most when evaluating pharma SEO vendors in 2026, plus pitch meeting questions and red flags.

TL;DR

A pharma SEO agency needs regulatory fluency, technical depth, and real capability in AI answer visibility, not just keyword rankings. Evaluate agencies on MLR review handling, HCP versus DTC content separation, HIPAA-conscious analytics, and measurement beyond rank tracking. Ask for named case studies with regulated brands and specific MLR feedback they have navigated. Walk away from anyone promising page-1 rankings in 30 days or suggesting link tactics that would never survive a compliance audit.

Table of Contents

Why Pharma SEO Is Not General B2B SEO

A generalist SEO agency can run a strong keyword gap analysis and still put your brand at risk the moment it touches content. Pharma marketing carries constraints most B2B SEO playbooks were never built for: promotional claims need substantiation, indications carry specific language requirements, and content describing a drug's benefit typically needs important safety information nearby, following fair balance principles that require risk information to carry weight comparable to efficacy claims.

Off-label promotion is a real legal exposure. An agency that cannot distinguish a mechanism of action from an implied unapproved use can generate content legal will never approve, or content that draws FDA Office of Prescription Drug Promotion (OPDP) attention. Most pharma content also passes through Medical, Legal, Regulatory (MLR) review before publication, so an agency's process matters as much as its SEO technique.

A post that ranks well but gets rejected in MLR review three times cost more than it gained. Agencies worth hiring treat pharma SEO as the intersection of search strategy, regulatory writing, and workflow.

1. Regulatory Fluency

Ask a candidate agency how they think about FDA promotional guidance before asking about keyword volume. A team with real fluency can speak specifically about what OPDP untitled and warning letters tend to cite, such as unsubstantiated superiority claims or omitted material facts, and how that shapes their writing. They should explain how they place the ISI so it supports compliance and readability, not as an afterthought.

Ask to see a real content brief template with built-in fields for indication language, claims substantiation, and citations. If it looks identical to a fintech client's template, that is a signal.

2. Technical SEO Depth

Pharma sites tend to be large and template-driven, with content that needs indexing carefully rather than everywhere. A capable agency should be fluent in structured data for medical content types, Core Web Vitals on compliance-heavy pages, and indexation strategy for HCP-only resources or country-specific label variants that need precision rather than default crawling.

Ask how they would approach a site with 40 country or indication variants of one drug page. If canonicalization, hreflang, and crawl budget do not come up immediately, they have not done this at scale.

3. AEO and GEO Capability

A growing share of how HCPs and patients find information runs through AI answer engines. When an HCP asks ChatGPT or Perplexity a clinical question, or Google's AI Overview summarizes a treatment category, a brand either shows up as a cited source or it does not. This is answer engine optimization and generative engine optimization: content structured around real HCP and patient questions, on a technical foundation that makes it easy for these systems to cite. Our guide to AI visibility for SEO and our breakdown of how AEO and GEO are changing B2B SEO for medtech and biotech companies go deeper on this shift.

Ask how a candidate agency measures share of voice in AI-generated answers. If they only discuss classic ranking positions, they are behind where the category needs to be in 2026.

4. HCP vs. DTC Content Separation

Most pharma brands run parallel content tracks, one for healthcare professionals and one for patients, each needing different clinical depth and often different access controls, since HCP-only resources are frequently gated behind a credential check. A good agency structures this split without damaging SEO on either side, keeping gated HCP content crawlable without leaking HCP-only claims into DTC results. See our guide to HCP versus patient marketing strategy in life sciences for more.

Ask how they would handle a gated HCP resource that needs to rank for a clinical term. If they have not solved this before, you will solve it together, on your budget.

5. Analytics Stack That Respects HIPAA

Analytics implementation in pharma is a compliance surface, not just a technical checkbox. A capable agency defaults to server-side tagging through Google Tag Manager rather than client-side tags, and builds tracking so no protected health information ever lands in a URL parameter, form field, or analytics event. Our HIPAA-compliant GA4 setup guide covers the choices that separate compliant analytics from liability.

Ask an agency to walk through their default GA4 and GTM setup. If PHI handling is not part of the first five minutes, keep asking.

6. MLR Workflow Integration

SEO content in pharma runs through Medical, Legal, and Regulatory review, often inside a platform like Veeva PromoMats, and review can take days to weeks depending on the brand and claims involved. An agency that builds calendars without accounting for MLR cycle time will miss deadlines and frustrate stakeholders. See our guide to MLR workflow automation for pharma marketing review for what a mature process looks like.

Ask how they structure the calendar around MLR turnaround and write briefs to reduce review rounds. Real experience shows in specific tactics, like submitting reference packets with the first draft, not a vague answer about working closely with legal.

7. Measurement Beyond Rankings

Keyword rank tracking is table stakes and, alone, tells you little about commercial impact. A stronger 2026 framework includes share of voice in AI-generated answers, directional signals tied to prescriber behavior where data permits, and the quality of patient inquiries, not just volume. A traffic spike from an unrelated audience is not a win if it does not reflect the HCPs or patients the brand needs to reach.

Ask what a monthly report looks like. If the sample is a list of keyword positions and nothing else, that previews the relationship a year in.

8. Case Studies With Regulated Brands

General case studies from e-commerce or SaaS clients say little about whether an agency can operate inside pharma's constraints. Ask for named case studies with regulated life sciences brands, plus concrete examples of MLR feedback they have navigated. Real experience shows in stories about specific claims language that got flagged and how they resolved it without losing the page's SEO value.

If an agency cannot name a single pharma or biotech client, or every example is vague beyond what confidentiality requires, treat that as a meaningful gap.

What to Ask in the Pitch Meeting

Bring these questions into the room and pay attention to how specifically the agency answers.

  • Walk me through a real MLR review cycle. What got flagged, and how did you resolve it?
  • Show me a content brief template you actually use for a pharma client.
  • How do you measure whether our brand shows up in AI-generated answers, not just Google results?
  • What is your default analytics and tagging setup for a client handling patient data?
  • How do you structure content differently for HCP audiences versus patients?
  • Name two regulated brands you have worked with and one compliance challenge from each.

Red Flags

Some warning signs should end the evaluation immediately, regardless of how strong the pitch looks.

  • Guaranteed page-1 rankings on a specific timeline. Promising page-1 rankings for a launch brand within 30 days signals inexperience or cut corners.
  • No MLR experience. If the team cannot describe a real review cycle in detail, they have not done this at scale.
  • Aggressive or black-hat link building on a pharma domain. Manipulative link tactics are risky on any domain, especially one regulators and journalists sometimes scrutinize.
  • No point of view on AI visibility. Selling SEO as classic rank tracking in 2026 is behind how HCPs and patients find information now.
  • Treats ISI and fair balance as legal's problem, not theirs. The best agencies build compliance into the content process.

FAQ

What makes pharma SEO different from healthcare SEO in general?

Healthcare SEO spans hospitals and digital health products, many without FDA promotional obligations. Pharma SEO deals specifically with prescription and OTC drug marketing, where every claim must reflect approved indications, fair balance, and MLR review before publishing.

How long does it take to see results from pharma SEO?

Typically 6 to 12 months, often longer than other industries because MLR review adds time between strategy and publication. Agencies promising fast results on a launch brand are usually ignoring this reality.

Do we need a separate agency for AEO and GEO, or should our SEO agency handle both?

One agency should handle both, since AEO and GEO extend the same discipline of making content clear, well-structured, and citable, whether the destination is a search page or an AI-generated answer. Splitting this across two vendors usually creates duplicated effort.

Should our SEO agency also manage our MLR submissions?

No. MLR review should stay owned by your internal medical, legal, and regulatory teams or your existing platform, such as Veeva PromoMats. The agency should build its process around your MLR timeline.

How much does a pharma SEO engagement typically cost?

Costs vary by brand count, content volume, and technical scope, and tend to run higher than general B2B SEO retainers because of the added regulatory review layer. Ask for a scope breakdown separating strategy, content, technical work, and reporting.

Can a small or mid-size pharma brand justify a dedicated pharma SEO agency instead of a generalist?

Yes, and arguably more so for smaller brands, which have less internal bandwidth to catch compliance issues a generalist might miss. A smaller budget does not reduce regulatory exposure.

These guides go deeper on the topics covered above.

Talk to XDS About Pharma SEO

If you are evaluating agencies against the criteria above and want a team that has navigated MLR review cycles, HCP content architecture, and AI visibility for regulated brands, we would welcome the conversation. I'm Shai Reichert, founder of XDS Health, and my team works with pharma and biotech brands on this kind of SEO program.

Reach out through our contact page and let's talk through what a program built for your brand's regulatory reality would look like.

Related Stories

All News